½ÃÀ庸°í¼­
»óǰÄÚµå
1660747

3D ÀÇ·á¿ë ¿µ»ó Àåºñ ½ÃÀå º¸°í¼­ : Á¦Ç°º°, ¼Ö·ç¼Çº°, ¿ëµµº°, ±¸¼º¿ä¼Òº°, Àü°³º°, Áö¿ªº°(2025-2033³â)

3D Medical Imaging Equipment Market Report by Product, Solution, Application, Component, Deployment, and Region 2025-2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 150 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

3D ÀÇ·á¿ë ¿µ»ó Àåºñ ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 137¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2025-2033³â ¿¬Æò±Õ ¼ºÀå·ü(CAGR) 4.32%·Î 2033³â¿¡´Â 200¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù. ÇコÄÉ¾î ºÐ¾ß¿¡¼­ ´õ ³ªÀº ¿µ»ó ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÷´Ü Áø´Ü µµ±¸ÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϸ鼭 ½ÃÀåÀÌ È°¼ºÈ­µÇ°í ÀÖ½À´Ï´Ù.

ÀÇ·á ¿µ»óÀº Áúº´ÀÇ ÀÓ»ó Áø´Ü ¹× ÈÄ¼Ó Ä¡·á¸¦ À§ÇØ ½Åü Àå±â¸¦ ½Ã°¢ÀûÀ¸·Î ¹¦»çÇÏ´Â ±â¼ú·Î, 3D À̹Ì¡ ±â¼úÀº ÀÇ·áÁøÀÌ ÀÎü¸¦ ´õ ±íÀÌ ÀÌÇØÇÒ ¼ö ÀÖµµ·Ï ¿©·¯ °¢µµ¿¡¼­ À̹ÌÁö¸¦ ÃÔ¿µÇϰí, ÇØ»óµµ¸¦ ³ôÀ̰í, ´õ º¹ÀâÇÑ ¼¼ºÎ »çÇ×°ú ÇÔ²² ´Ù¾çÇÑ ±íÀÌÀÇ Á¶Á÷À» Ç¥½ÃÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. À߸øµÈ °á°ú¸¦ ÃÊ·¡ÇÒ ¼ö ÀÖ¾ú´ø ÀÌÀü ¿µ»ó ±â¼ú°ú ´Þ¸® 3D ¿µ»ó ±â¼úÀº ¸ðµç Áúº´ Áø´Ü¿¡ ÀÖ¾î Á¤È®ÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. À¯¹æ¾Ï Ä¡·á¿¡ Áß¿äÇÑ µðÁöÅÐ À¯¹æ Åä¸ð½Å½Ã½º(DBT) µî ´Ù¾çÇÑ Áúº´ Áø´Ü¿¡ Çõ¸íÀûÀÎ È¿°ú¸¦ ¹ßÈÖÇϰí ÀÖ½À´Ï´Ù.

ÇコÄÉ¾î »ê¾÷ÀÇ ¹ø¿µÀº ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â Áß¿äÇÑ ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ÁÂ½Ä »ýȰ½À°ü°ú °í·É Àα¸ÀÇ ±Þ°ÝÇÑ Áõ°¡·Î ÀÎÇØ »ýȰ½À°üº´ ¹× ³ëÈ­ °ü·Ã ÁúȯÀÇ ¹ß»ýÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±× °á°ú, ÇコÄÉ¾î ºÐ¾ß¿¡¼­ 3D ÀÇ·á¿ë ¿µ»ó ó¸® Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±â¼úÀÇ ¹ßÀü°ú ÇÔ²² ³»ºÎ Àå±âÀÇ Á¤È®ÇÑ ½Ã°¢Àû Ç¥Çö, ÁÖº¯ Á¶Á÷ ¼Õ»ó °¨¼Ò, ´Ù¾çÇÑ ÀÇ·á ¿µ»ó 󸮿¡¼­ Á¦°øµÇ´Â µ¥ÀÌÅÍÀÇ Á¤È®¼º µî ÀÌ ±â¼úÀÇ ÀåÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àü ¼¼°è °¢±¹ Á¤ºÎÀÇ ÀÇ·á ¿¹»ê ¹èºÐ ¹× ¿¬±¸°³¹ß(R&D) Ȱµ¿ÀÇ Áõ°¡°¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

  • 2024³â ¼¼°è 3D ÀÇ·á¿ë ¿µ»ó Àåºñ ½ÃÀå ±Ô¸ð´Â?
  • 2025-2033³â ¼¼°è 3D ÀÇ·á¿ë ¿µ»ó Àåºñ ½ÃÀå ¼ºÀå·ü Àü¸ÁÀº?
  • ¼¼°è 3D ÀÇ·á¿ë ¿µ»ó Àåºñ ½ÃÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
  • COVID-19°¡ ¼¼°è 3D ÀÇ·á¿ë ¿µ»ó Àåºñ ½ÃÀå ¼ºÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀº?
  • Àü ¼¼°è 3D ÀÇ·á¿ë ¿µ»ó Àåºñ ½ÃÀåÀÇ Á¦Ç°º° ½ÃÀå ÇöȲÀº?
  • ¼¼°è 3D ÀÇ·á¿ë ¿µ»ó Àåºñ ½ÃÀåÀÇ ¼Ö·ç¼Çº° ºÐ¼®Àº?
  • Àü ¼¼°è 3D ÀÇ·á¿ë ¿µ»ó Àåºñ ½ÃÀåÀÇ ¿ëµµº° ½ÃÀå ÇöȲÀº?
  • ¼¼°è 3D ÀÇ·á¿ë ¿µ»ó Àåºñ ½ÃÀåÀÇ ±¸¼º¿ä¼Òº° ½ÃÀå ÇöȲÀº?
  • Àü ¼¼°è 3D ÀÇ·á¿ë ¿µ»ó Àåºñ ½ÃÀå ÇöȲÀº?
  • Àü ¼¼°è 3D ÀÇ·á¿ë ¿µ»ó Àåºñ ½ÃÀåÀÇ ÁÖ¿ä Áö¿ªÀº?
  • ¼¼°è 3D ÀÇ·á¿ë ¿µ»ó Àåºñ ½ÃÀåÀÇ ÁÖ¿ä Ç÷¹À̾î/±â¾÷Àº?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»ç ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • »óÇâ½Ä Á¢±Ù
    • ÇÏÇâ½Ä Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

  • °³¿ä
  • ÁÖ¿ä ¾÷°è µ¿Çâ

Á¦5Àå ¼¼°èÀÇ 3D ÀÇ·á¿ë ¿µ»ó Àåºñ ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ³»¿ª : Á¦Ç°º°
  • ½ÃÀå ³»¿ª : ¼Ö·ç¼Ç
  • ½ÃÀå ³»¿ª : ¿ëµµº°
  • ½ÃÀå ³»¿ª : ±¸¼º¿ä¼Òº°
  • ½ÃÀå ³»¿ª : Àü°³º°
  • ½ÃÀå ³»¿ª : Áö¿ªº°
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ³»¿ª : Á¦Ç°º°

  • X¼±
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ÃÊÀ½ÆÄ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • MRI
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • CT ½ºÄµ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ÇÏÀ̺긮µå À̹Ì¡
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦7Àå ½ÃÀå ³»¿ª : ¼Ö·ç¼Çº°

  • 3D ½ºÄµ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • 3D ·»´õ¸µ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • 3D ¸ðµ¨¸µ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦8Àå ½ÃÀå ³»¿ª : ¿ëµµº°

  • Á¾¾çÇÐ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ½ÉÀ庴ÇÐ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • Á¤Çü¿Ü°ú
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±âŸ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦9Àå ½ÃÀå ³»¿ª : ±¸¼º¿ä¼Òº°

  • Çϵå¿þ¾î
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ¼ÒÇÁÆ®¿þ¾î
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ¼­ºñ½º
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦10Àå ½ÃÀå ³»¿ª : Àü°³º°

  • ¿ÂÇÁ·¹¹Ì½º ±â¹Ý Ç÷§Æû
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • Ŭ¶ó¿ìµå ±â¹Ý Ç÷§Æû
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • À¥ ±â¹Ý Ç÷§Æû
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦11Àå ½ÃÀå ³»¿ª : Áö¿ªº°

  • ºÏ¹Ì
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • À¯·´
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦12Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦13Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦14Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • °æÀï Á¤µµ
  • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦15Àå °¡°Ý ºÐ¼®

Á¦16Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • GE Healthcare
    • Philips Electronics Nederland B.V.
    • Siemens Healthineers
    • FUJIFILM Corporation
    • Analogic Corporation
    • ContextVision AB
    • Dentsply Sirona
    • EOS imaging
    • Esaote S.p.A
    • Fuel 3D Technologies Limited
    • KaVo Dental GmbH
    • Hologic, Inc.
    • Intelerad Medical Systems
    • Planmeca Group
    • Samsung Medison
    • Shimadzu Corporation
ksm 25.03.11

The global 3D medical imaging equipment market size reached USD 13.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 20.0 Billion by 2033, exhibiting a growth rate (CAGR) of 4.32% during 2025-2033. The increasing demand for better imaging solutions in healthcare is raising the adoption of advanced diagnostic tools, which is catalyzing the market.

Medical imaging is a technique of creating visual depictions of internal organs in the body for the clinical diagnosis of an ailment and its subsequent medical treatment. The 3D imaging technology has aided healthcare professionals to capture images at multiple angles and display tissues at varying depths along with enhanced resolutions and more intricate details to provide a better understanding of the human body. Unlike previously used imaging technologies which had possibilities of erroneous results, the 3D imaging technology offers precise information during the diagnosis of any medical ailment. It has proved revolutionary in the diagnosis of various medical illnesses, including digital breast tomosynthesis (DBT), which is crucial in the treatment of breast cancer

The thriving healthcare industry is one of the key factors driving market growth. There has been a rise in the occurrence of lifestyle diseases along with age-related ailments owing to sedentary lifestyles and a significant increase in the geriatric population, respectively. This has consequently bolstered the demand for 3D medical imaging equipment in the healthcare sector. Moreover, technological advancements coupled with the rising awareness about the benefits of this technology such as an accurate visual representation of internal organs, reduced damage to surrounding tissues and accuracy of data offered by various medical imaging procedures has stimulated the market growth. The market is further driven by increasing healthcare budgetary allocations and research and development (R&D) activities by governments of various nations across the globe.

Key Market Segmentation:

Breakup by Product:

  • X-Ray
  • Ultrasound
  • MRI
  • CT Scan
  • Hybrid Imaging

Breakup by Solution:

  • 3D Scanning
  • 3D Rendering
  • 3D Modeling

Breakup by Application:

  • Oncology
  • Cardiology
  • Orthopedics
  • Others

Breakup by Component:

  • Hardware
  • Software
  • Service

Breakup by Deployment:

  • On-Premise Based Platform
  • Cloud Based Platform
  • Web Based Platform

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being GE Healthcare, Philips Electronics Nederland B.V., Siemens Healthineers, FUJIFILM Corporation, Analogic Corporation, ContextVision AB, Dentsply Sirona, EOS imaging, Esaote S.p.A, Fuel 3D Technologies Limited, KaVo Dental GmbH, Hologic, Inc., Intelerad Medical Systems, Planmeca Group, Samsung Medison and Shimadzu Corporation.

IMARC Group's latest report provides a deep insight into the global 3D medical imaging equipment market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global 3D medical imaging equipment market in any manner.

Key Questions Answered in This Report

  • 1.What was the size of the global 3D medical imaging equipment market in 2024?
  • 2.What is the expected growth rate of the global 3D medical imaging equipment market during 2025-2033?
  • 3.What are the key factors driving the global 3D medical imaging equipment market?
  • 4.What has been the impact of COVID-19 on the global 3D medical imaging equipment market growth?
  • 5.What is the breakup of the global 3D medical imaging equipment market based on the product?
  • 6.What is the breakup of the global 3D medical imaging equipment market based on the solution?
  • 7.What is the breakup of the global 3D medical imaging equipment market based on the application?
  • 8.What is the breakup of the global 3D medical imaging equipment market based on the component?
  • 9.What is the breakup of the global 3D medical imaging equipment market based on the deployment?
  • 10.What are the key regions in the global 3D medical imaging equipment market?
  • 11.Who are the key players/companies in the global 3D medical imaging equipment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global 3D Medical Imaging Equipment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product
  • 5.5 Market Breakup by Solution
  • 5.6 Market Breakup by Application
  • 5.7 Market Breakup by Component
  • 5.8 Market Breakup by Deployment
  • 5.9 Market Breakup by Region
  • 5.10 Market Forecast

6 Market Breakup by Product

  • 6.1 X-Ray
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Ultrasound
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 MRI
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 CT Scan
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Hybrid Imaging
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Solution

  • 7.1 3D Scanning
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 3D Rendering
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 3D Modeling
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cardiology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Orthopedics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Component

  • 9.1 Hardware
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Software
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Service
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Deployment

  • 10.1 On-Premise Based Platform
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Cloud Based Platform
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Web Based Platform
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Europe
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Asia Pacific
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast
  • 11.4 Middle East and Africa
    • 11.4.1 Market Trends
    • 11.4.2 Market Forecast
  • 11.5 Latin America
    • 11.5.1 Market Trends
    • 11.5.2 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 GE Healthcare
    • 16.3.2 Philips Electronics Nederland B.V.
    • 16.3.3 Siemens Healthineers
    • 16.3.4 FUJIFILM Corporation
    • 16.3.5 Analogic Corporation
    • 16.3.6 ContextVision AB
    • 16.3.7 Dentsply Sirona
    • 16.3.8 EOS imaging
    • 16.3.9 Esaote S.p.A
    • 16.3.10 Fuel 3D Technologies Limited
    • 16.3.11 KaVo Dental GmbH
    • 16.3.12 Hologic, Inc.
    • 16.3.13 Intelerad Medical Systems
    • 16.3.14 Planmeca Group
    • 16.3.15 Samsung Medison
    • 16.3.16 Shimadzu Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦